Skip to main content
. 2014 Feb 14;9(2):e88735. doi: 10.1371/journal.pone.0088735

Figure 4. Virus infectivity neutralising activity following vaccination with inactivated SIV.

Figure 4

Neutralising antibody activity against SHIVW61D propagated on human C8166 cells in sera from macaques immunised with SIV-containing vaccines in the absence (left panel) or presence (right panel) of complement. Pre-immune sera (black line) are means of all animals with standard deviations. Group A immunised with 500 µg of inactivated SIV (red lines); group B immunised with 100 µg of inactivated SIV (blue lines) group C immunised with SIV-infected C8166 cells (green lines). Dashed lines indicate unprotected animals.